StockData
VolitionRx Ltd logo

VolitionRx Ltd (VNRX) stock

VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.16−0.02 (-10.00%)

Close on Nov 19, 2026Market cap $2.25MP/E –Yield –

VolitionRx shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

VolitionRx's shares outstanding was 9M at Jun 30, 2026. For fiscal 2025 it was 5M, up 23.5% from the year before. Over ten years it grew 23.0% a year on average. The highest annual figure on record is 5M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20255M+23.5%
FY2024Dec 31, 20244M+21.5%
FY2023Dec 31, 20234M+35.3%
FY2021Dec 31, 20213M+16.3%
FY2020Dec 31, 20202M+15.6%
FY2019Dec 31, 20192M+24.8%
FY2018Dec 31, 20182M+18.9%
FY2017Dec 31, 20171M+14.5%
FY2016Dec 31, 20161M+30.0%
FY2015Dec 31, 20151M+32.0%
FY2014Dec 31, 20141M+24.0%
FY2013Dec 31, 20131M+15.7%
FY2012Dec 31, 20120M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20269M+78.4%
Q1 FY2026Mar 31, 20267M+42.6%
Q4 FY2025Dec 31, 20256M+29.2%
Q3 FY2025Sep 30, 20255M+23.1%
Q2 FY2025Jun 30, 20255M+24.2%
Q1 FY2025Mar 31, 20255M+17.8%
Q4 FY2024Dec 31, 20245M+74.8%
Q3 FY2024Sep 30, 20244M+65.3%
Q2 FY2024Jun 30, 20244M+56.1%
Q1 FY2024Mar 31, 20244M+60.9%
Q4 FY2021Dec 31, 20213M+10.0%
Q3 FY2021Sep 30, 20213M+13.1%
Q2 FY2021Jun 30, 20213M+22.0%
Q1 FY2021Mar 31, 20213M+23.6%
Q4 FY2020Dec 31, 20202M+18.4%
Q3 FY2020Sep 30, 20202M+17.9%
Q2 FY2020Jun 30, 20202M+11.7%
Q1 FY2020Mar 31, 20202M+13.8%
Q4 FY2019Dec 31, 20192M+16.3%
Q3 FY2019Sep 30, 20192M+21.5%
Q2 FY2019Jun 30, 20192M+29.5%
Q1 FY2019Mar 31, 20192M+32.8%
Q4 FY2018Dec 31, 20182M+33.2%
Q3 FY2018Sep 30, 20182M+23.8%
Q2 FY2018Jun 30, 20182M+13.8%
Q1 FY2018Mar 31, 20181M+4.3%
Q4 FY2017Dec 31, 20171M+2.2%
Q3 FY2017Sep 30, 20171M+12.7%
Q2 FY2017Jun 30, 20171M–
Q1 FY2017Mar 31, 20171M–
Q4 FY2016Dec 31, 20161M–
Q3 FY2016Sep 30, 20161M–

More VolitionRx figures

See a number that looks wrong?